Page last updated: 2024-08-18

obidoxime chloride and Encephalopathy, Toxic

obidoxime chloride has been researched along with Encephalopathy, Toxic in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horova, A; Kassa, J; Matouskova, L; Musilek, K; Sepsova, V1
Bajgar, J; Karasova, J; Kassa, J; Kuca, K; Musilek, K; Vasina, L1
Largu, E; Lionte, C; Petriş, O; Sorodoc, L1
Karasova, JZ; Kassa, J; Misik, J1
Jung, YS; Karasova, JZ; Kassa, J; Kuca, K; Musilek, K; Tesarova, S1
Karasova, J; Kassa, J2

Other Studies

7 other study(ies) available for obidoxime chloride and Encephalopathy, Toxic

ArticleYear
A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
    Toxicology mechanisms and methods, 2015, Volume: 25, Issue:3

    Topics: Acetylcholinesterase; Animals; Animals, Outbred Strains; Antidotes; Atropine; Brain; Cholinesterase Inhibitors; Cholinesterase Reactivators; Diaphragm; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Mice; Muscarinic Antagonists; Nerve Tissue Proteins; Neurons; Neurotoxicity Syndromes; Obidoxime Chloride; Oximes; Pyridinium Compounds; Rats, Wistar; Sarin

2015
A comparison of neuroprotective efficacy of newly developed oximes (K203, K206) and commonly used oximes (obidoxime, HI-6) in tabun-poisoned rats.
    Drug and chemical toxicology, 2009, Volume: 32, Issue:2

    Topics: Animals; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Disease Models, Animal; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Obidoxime Chloride; Organophosphates; Organophosphorus Compounds; Oximes; Rats; Rats, Wistar

2009
Benefits of butyrylcholinesterase reactivability testing in organophosphate poisoning.
    Human & experimental toxicology, 2011, Volume: 30, Issue:11

    Topics: Adult; Butyrylcholinesterase; Cholinesterase Reactivators; Female; Humans; Male; Middle Aged; Neurotoxicity Syndromes; Obidoxime Chloride; Organophosphate Poisoning; Reagent Kits, Diagnostic; Young Adult

2011
A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats.
    Basic & clinical pharmacology & toxicology, 2012, Volume: 111, Issue:5

    Topics: Animals; Antidotes; Atropine; Autonomic Nervous System; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Czech Republic; Drug Therapy, Combination; Lethal Dose 50; Male; Muscarinic Antagonists; Neurons; Neurotoxicity Syndromes; Obidoxime Chloride; Oximes; Psychomotor Performance; Pyridinium Compounds; Rats; Rats, Wistar; Sarin

2012
A comparison of neuroprotective efficacy of the oxime K203 and its fluorinated analogue (KR-22836) with obidoxime in Tabun-poisoned rats.
    Basic & clinical pharmacology & toxicology, 2010, Volume: 107, Issue:5

    Topics: Acute Disease; Animals; Autonomic Nervous System; Behavior, Animal; Chemical Warfare Agents; Hyperkinesis; Male; Molecular Structure; Muscle Tonus; Neuroprotective Agents; Neurotoxicity Syndromes; Obidoxime Chloride; Organophosphate Poisoning; Organophosphates; Oximes; Pyridinium Compounds; Rats; Rats, Wistar; Treatment Outcome

2010
A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
    Toxicology, 2007, Jan-05, Volume: 229, Issue:1-2

    Topics: Animals; Antidotes; Atropine; Behavior, Animal; Butanes; Chemical Warfare Agents; Cholinergic Antagonists; Dose-Response Relationship, Drug; Injections, Intramuscular; Lacrimal Apparatus; Male; Miosis; Molecular Structure; Muscle Tonus; Neurotoxicity Syndromes; Obidoxime Chloride; Organophosphates; Oximes; Pyridinium Compounds; Rats; Rats, Wistar; Tears; Time Factors; Toxicity Tests; Treatment Outcome

2007
A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) to counteract soman-induced neurotoxicity in rats.
    Drug and chemical toxicology, 2007, Volume: 30, Issue:2

    Topics: Animals; Antidotes; Atropine; Autonomic Nervous System; Behavior, Animal; Butanes; Chemical Warfare Agents; Cholinesterase Reactivators; Drug Therapy, Combination; Male; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Obidoxime Chloride; Oximes; Pyridinium Compounds; Rats; Rats, Wistar; Soman; Structure-Activity Relationship

2007